Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
作者信息
Nordoy A, Gjone E
出版信息
Acta Med Scand. 1970 Dec;188(6):487-90. doi: 10.1111/j.0954-6820.1970.tb08073.x.
Abstract
摘要
相似文献
1
Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
Acta Med Scand. 1970 Dec;188(6):487-90. doi: 10.1111/j.0954-6820.1970.tb08073.x.
2
Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
Acta Med Scand. 1971 May;189(5):385-9.
3
[Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
Lakartidningen. 1971 Apr 7;68(15):1769-72.
4
[The treatment of essential hyperlipidemia with clofibrate].
Z Gesamte Inn Med. 1969 Jan 1;24(1):Suppl:184-7.
5
Diet and drug therapy for hyperlipoproteinemia.
Med Times. 1971 Aug;99(8):49-63 passim.
6
Xanthomatosis associated with hyperlipoproteinemia.
J Invest Dermatol. 1970 Aug;55(2):71-88. doi: 10.1111/1523-1747.ep12291505.
7
[Treatment of essential hyperlipemia with clofibrate].
Z Gesamte Inn Med. 1969 Jun 15;24(12):184-7.
8
Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
Acta Med Scand. 1970 Mar 3;187(3):213-8.
9
Management of the hyperlipidemic patient.
Med Clin North Am. 1973 Jul;57(4):881-92. doi: 10.1016/s0025-7125(16)32239-8.
10
A comparison of fenofibrate and clofibrate hypolipidemic effects.
Acta Clin Belg. 1980;35(4):227-32. doi: 10.1080/22953337.1980.11718748.
Zotero 插件